TLSI vs ELPW Comparison

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Elong Power Holding Ltd is engaged in research and development, manufacturing, sales, and service of high-power lithium-ion batteries for electric vehicles and construction machinery, as well as large-capacity, long-cycle lithium-ion batteries for energy storage systems. The company's lower-cost, high-power, and fast-charging batteries are designed specifically for commercial vehicles and specialty vehicles that require large-capacity energy storage systems. It operates in one operating segment and includes the manufacture, commercialization, and distribution of a variety of battery cells and battery packs for use in a wide array of applications.